Cite
Efficacy of nano‐particulated, water‐soluble erlotinib against intracranial metastases of EGFR‐mutant lung cancer
MLA
Ki Jung Sung, et al. “Efficacy of Nano‐particulated, Water‐soluble Erlotinib against Intracranial Metastases of EGFR‐mutant Lung Cancer.” Molecular Oncology, vol. 12, no. 12, Dec. 2018, pp. 2182–90. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c5a879a335fd540be90f6d32e2fb8b4&authtype=sso&custid=ns315887.
APA
Ki Jung Sung, Dong Ha Kim, Eun Yong Lee, Jin Kyung Rho, Jae Cheol Lee, Seon-A Yoo, Seungho Cook, Yun Jung Choi, Jeong Kon Kim, Yong Suk Jin, Young Hoon Sung, Chang-Min Choi, & Miyong Yun. (2018). Efficacy of nano‐particulated, water‐soluble erlotinib against intracranial metastases of EGFR‐mutant lung cancer. Molecular Oncology, 12(12), 2182–2190.
Chicago
Ki Jung Sung, Dong Ha Kim, Eun Yong Lee, Jin Kyung Rho, Jae Cheol Lee, Seon-A Yoo, Seungho Cook, et al. 2018. “Efficacy of Nano‐particulated, Water‐soluble Erlotinib against Intracranial Metastases of EGFR‐mutant Lung Cancer.” Molecular Oncology 12 (12): 2182–90. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c5a879a335fd540be90f6d32e2fb8b4&authtype=sso&custid=ns315887.